Filter News
Area of Research
- (-) Neutron Science (3)
- (-) Nuclear Science and Technology (2)
- Advanced Manufacturing (2)
- Biology and Environment (7)
- Clean Energy (16)
- Climate and Environmental Systems (1)
- Computational Biology (1)
- Computational Engineering (1)
- Isotopes (11)
- Materials (13)
- Materials for Computing (5)
- Mathematics (1)
- National Security (1)
- Supercomputing (9)
News Type
News Topics
- (-) Artificial Intelligence (2)
- (-) Composites (1)
- (-) Isotopes (2)
- 3-D Printing/Advanced Manufacturing (2)
- Advanced Reactors (1)
- Bioenergy (1)
- Biology (2)
- Biomedical (4)
- Chemical Sciences (1)
- Computer Science (5)
- Coronavirus (2)
- Fusion (1)
- High-Performance Computing (1)
- Materials (3)
- Materials Science (7)
- Microscopy (1)
- Molten Salt (3)
- Nanotechnology (3)
- Neutron Science (19)
- Nuclear Energy (5)
- Physics (2)
- Quantum Computing (1)
- Quantum Science (2)
- Space Exploration (1)
- Transportation (2)
Media Contacts
![An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-06/frame1.png?h=d1cb525d&itok=51pwBWyP)
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
![ORNL’s Sergei Kalinin and Rama Vasudevan (foreground) use scanning probe microscopy to study bulk ferroelectricity and surface electrochemistry -- and generate a lot of data. Credit: Jason Richards/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-05/KalininVasudevan_2017-P03014_0.jpg?h=1116cd87&itok=KEEOB4hi)
At the Department of Energy’s Oak Ridge National Laboratory, scientists use artificial intelligence, or AI, to accelerate the discovery and development of materials for energy and information technologies.
![Using as much as 50 percent lignin by weight, a new composite material created at ORNL is well suited for use in 3D printing. Using as much as 50 percent lignin by weight, a new composite material created at ORNL is well suited for use in 3D printing.](/sites/default/files/styles/list_page_thumbnail/public/2018-P09551.jpg?itok=q7Ri01Qb)
Scientists at the Department of Energy’s Oak Ridge National Laboratory have created a recipe for a renewable 3D printing feedstock that could spur a profitable new use for an intractable biorefinery byproduct: lignin.
![The electromagnetic isotope separator system operates by vaporizing an element such as ruthenium into the gas phase, converting the molecules into an ion beam, and then channeling the beam through magnets to separate out the different isotopes. The electromagnetic isotope separator system operates by vaporizing an element such as ruthenium into the gas phase, converting the molecules into an ion beam, and then channeling the beam through magnets to separate out the different isotopes.](/sites/default/files/styles/list_page_thumbnail/public/6_1_17%20Ru_NF3_530uA%5B2%5D.jpg?itok=3OLnNZqa)
A tiny vial of gray powder produced at the Department of Energy’s Oak Ridge National Laboratory is the backbone of a new experiment to study the intense magnetic fields created in nuclear collisions.
![Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227. Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227.](/sites/default/files/styles/list_page_thumbnail/public/2016-P07827%5B1%5D.jpg?itok=yJbnFQLU)
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.